Life Sciences Virtual Investor Forum - Beyond Air, Inc. (Nasdaq: XAIR) скачать в хорошем качестве

Life Sciences Virtual Investor Forum - Beyond Air, Inc. (Nasdaq: XAIR)

This video is part of the ‪‪@OTCMarketsGroup‬ Life Sciences Virtual Investor Forum Hosted by Virtual Investor Conferences, a ‪‪@b2idigital‬ Featured Conference, held on March 11th & 12th, 2026. BeyondAir, Inc. (Nasdaq: XAIR) is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. Beyond Air is currently advancing its other revolutionary LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria (NTM). Additionally, Beyond Cancer, Ltd., an affiliate of Beyond Air, is investigating ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting. For more information, visit www.beyondair.net. Watch the full Beyond Air, Inc. (Nasdaq: XAIR) presentation and request meetings with management at: https://www.virtualinvestorconference... Any questions or need assistance setting up meetings, contact Joseph Azizo, Capital Markets Associate at B2i Digital: joseph@b2idigital.com